Charles Carignan

President and CEO,
NinePoint Medical, Inc.

Charles brings extensive experience in medical device development with more than 20 years dedicated to medicine and the health care industry, with a focus on minimally invasive technologies. As Executive Vice President and Chief Medical officer of Novasys Medical, Inc. he launched the Renessa treatment for female stress incontinence. As Chief Medical Officer, at Boston Scientific, Charles led all aspects of medical and clinical affairs for the Endosurgery group, including women’s health, urology, gastroenterology, pulmonology, and oncology. At Conceptus, Inc., he was Vice President, Clinical Research and Medical Affairs, responsible for large multicenter clinical trials, leading to expedited review and PMA approval by the FDA of the Essure female sterilization device. Charles has conducted physician training in more than 50 countries and participated on various committees of the World Health Organization, the Population Council, the United Nations and the U.S. Agency for International Development. He is credited with numerous peer-reviewed publications focused on women’s health. Charles earned his undergraduate degree from Yale University, received his M.D. degree from the College of Physicians and Surgeons of Columbia University and trained in general surgery at Columbia-Presbyterian Medical Center.